Lund, Sweden

Erik Torgny

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Erik Torgny in Renal Failure Therapy

Introduction

Erik Torgny is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of renal failure therapy, holding a total of 5 patents. His work focuses on developing systems that enhance the safety and efficacy of treatments for renal failure patients.

Latest Patents

Among his latest patents, Erik has developed a renal failure therapy system and method for electrically safe treatment. This innovative system includes a dialyzer, a blood circuit in fluid communication with the dialyzer, and a dialysis fluid circuit also in fluid communication with the dialyzer. The design features a housing that supports these components and includes at least one electrical socket. This socket provides a voltage output dedicated to a specific type of external electrical device, ensuring patient safety while powering or charging the device.

Another significant patent by Erik is a renal failure therapy system that features an electrically floating fluid pathway. This system includes a dialyzer and both blood and dialysis fluid circuits. The electrically floating fluid pathway allows for a unique electrical path to ground, which is achieved through used dialysis fluid traveling to earth ground. This design enables certain electrical components within the dialysis fluid circuit to be electrically bypassed, enhancing the safety of the system.

Career Highlights

Erik Torgny has been instrumental in advancing renal therapy technologies through his innovative designs. His work at Gambro Lundia AB has positioned him as a key figure in the development of safer and more effective renal treatment systems.

Collaborations

Erik has collaborated with notable colleagues such as Sture Hobro and Par Lofgren. Their combined expertise has contributed to the successful development of advanced renal therapy solutions.

Conclusion

Erik Torgny's contributions to renal failure therapy through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the field and enhance the safety of renal treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…